| Titolo |
Pubblicato in |
Anno |
| Chronic inflammatory demyelinating polyneuropathy and HEV antibody
status: A case-control study from Lazio, Italy |
JOURNAL OF THE NEUROLOGICAL SCIENCES |
2024 |
| Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study |
LANCET NEUROLOGY |
2023 |
| Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients |
NEUROLOGICAL SCIENCES |
2023 |
| Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv pre‐symptomatic carriers: relationships with predicted time of disease onset (PADO) |
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM |
2023 |
| Prominent mitochondrial pathology in a case of refractory dermatomyositis: coincidence or concause? |
NEUROLOGICAL SCIENCES |
2023 |
| Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors |
NEUROLOGICAL SCIENCES |
2023 |
| Muscle MRI in immune-mediated necrotizing myopathy (IMNM). implications for clinical management and treatment strategies |
JOURNAL OF NEUROLOGY |
2022 |
| Distal upper limb involvement in myasthenia-myositis association |
NEUROLOGICAL SCIENCES |
2022 |
| Nerve high-resolution ultrasound in a 2-years follow-up of radial nerve palsy related to humeral shaft fractures |
JOURNAL OF NEUROSURGICAL SCIENCES |
2022 |
| Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up |
JOURNAL OF NEUROLOGY |
2021 |
| Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension |
NEUROLOGY |
2021 |
| Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation |
NEUROLOGICAL SCIENCES |
2021 |
| Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT). a multicentre, randomised, placebo-controlled, phase 3 trial |
LANCET NEUROLOGY |
2021 |
| High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP |
NEUROLOGICAL SCIENCES |
2021 |
| Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials |
EUROPEAN JOURNAL OF NEUROLOGY |
2021 |
| Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study |
MUSCLE & NERVE |
2021 |
| Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patients |
AUTOIMMUNITY REVIEWS |
2020 |
| Minimal Symptom Expression' in Patients With Acetylcholine Receptor Antibody-Positive Refractory Generalized Myasthenia Gravis Treated With Eculizumab |
JOURNAL OF NEUROLOGY |
2020 |
| Consistent improvement with eculizumab across muscle groups in myasthenia gravis |
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY |
2020 |
| Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy |
NEUROLOGICAL SCIENCES |
2020 |
